Efficacy of Ganoderma lucidum on plasma lipids and lipoproteins in rats fed with high cholesterol diet

Nutrition and Food Science

Volumn 38, Issue 3, 2008, Pages 229-238

  Tong, Chow Chin ^a   Choong, Yew Keong ^a   Mohamed, S ^a   Mohamed, Noordin M ^a   Aini, Nor Aini Umar ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Alternative medicines; Diet; Malaysia

Indexed keywords

GANODERMA; GANODERMA LUCIDUM; RATTUS;

EID: 44049094346     PISSN: 00346659     EISSN: None     Source Type: Journal    
DOI: 10.1108/00346650810871911     Document Type: Article

References (23)

1. Chen, Q. (1986), "Linzhi", in Chang, H.M. and But, P.P.-H. (Eds), Pharmacology and Applications of Chinese Materia Medica, World Sci. Publ. Co, Singapore, Vol. 1, pp. 642-53.
2. Cheng, H.H., Tung, Y.C. and Tung, T.C. (1986), "The antitumor effect of cultivated Ganoderma lucidum extract. III. Effect of Ganoderma lucidum extract on human T-cell subsets", Journal of Chinese Oncology Society, Vol. 1, pp. 1-10.
3. Chen, R.Y. and Yu, D.Q. (1993), "Studies on the triterpenoid constituents of the spores from Ganoderma lucidum Karst", Journal of Chinese Pharmaceutical Sciences, Vol. 2, pp. 91-6.
4. Grone, H.J., Walli, A., Grone, E., Niedmann, P., Thiery, I., Seidel, D. and Helmchen, U. (1989), "Induction of glomerulosclerosis by dietary lipids", Laboratory Investigation, Vol. 60 No. 3, pp. 433-46.
5. Hayes, K.C., Khosia, P. and Pronczuk, A. (1991), "Diet-induced type IV-like hyperlipidemia and Increase body weight are associated with cholesterol galltones in hamster", Lipids, Vol. 26 No. 9, pp. 729-35.
6. Hikino, H., Konno, C., Mirin, Y. and Hayashi, T. (1985), "Antidiabetes drugs: Isolation and hypoglycemic activity of ganoderan A and ganoderan B, glycans of Ganoderma lucidum fruit bodies", Planta Medica, Vol. 51, pp. 339-40.
7. Kim, B.K., Kim, H.W. and Choi, E.C. (1993), "Anti-HIV activities of Ganoderma lucidum", 5th International Symposium on Ganoderma lucidum, Seoul, Korea, pp. 67-9.
8. Komoda, Y., Shimizu, M., Sonoda, Y. and Sato, Y. (1989), "Ganoderic acid and its derivatives as cholesterol synthesis inhibitors", Chemical & Pharmaceutical Bulletin, Vol. 37, pp. 531-3.
9. Lindequist, U. (1995), "Structure and biological activity of triterpenes, polysaccharides and other constituents of Ganoderma lucidum", in Kim, B.K., Kim, I.H. and Kim, Y.S. (Eds), Recent Advances in Ganoderma lucidum Research, Pharmaceutical Society of Korea, Seoul, pp. 61-92.
10. Luu, B. (1992), "Chemistry and biology of oxysterols and oxytriterpenes", 4th International Symposium on Ganoderma lucidum, Seoul, Korea, pp. 49-50.
11. Marenah, C.B. (1995), "Lipid metabolism, hyper- and hypolipiduemias and atherosclerosis", in Clinical Biochemistry Metabolic & Clinical Aspects, Churdrill Livingstone, p. 622.
12. Morigiwa, A., Kitabatake, K., Fujimoto, Y. and Ikekawa, N. (1986), "Angiotensin converting enzyme-inhibiting triterpenes from Ganoderma lucidum", Chemical & Pharmaceutical Bulletin, Vol. 34, pp. 3025-8.
13. Rifai, N., Warnick, G.R., Mc Namara, J.R., Belcher, J.D., Grinstead, G.F. and Frantz, I.D., Jr. (1992), "Measurement of low density lipoprotein cholesterol in serum: A status report", Clinical Chemistry, Vol. 38 No.1, pp. 150-60.
14. Paszty, C., Maeda, N., Verstuyft, J. and Rubin, E.M. (1994), "Apolipoprotein altransgene corrects apolipoprotein of deficiency-induced atherosclerosis in mice", The Journal of Clinical Investigation, Vol. 94, pp. 899-903.
15. Seung, Y.L. and Hee, M.R. (1990), "Cardiovascular effects of mycelium extract of Ganoderma lucidum: Inhibition of sympathetic outflow as a mechanism of its hypotensive action", Chemical & Pharmaceutical Bulletin, Vol. 38 No. 5, pp. 1359-64.
16. Sohn, D.H. (1995), "Antifibrolic effect of polysaccharides from Ganoderma lucidum in experimental hepatic cirrhosis model", in Kim, B.K. et al. (Eds), Recent Advances in Ganoderma lucidum Research, The Pharmaceutical Society of Korea, Seoul, pp. 29-41.
17. Stephane, P., Legendre, C., Matsauru, A., Guffroy, C., Binet, J., Ohbayashi, S., Tanaka, T., Ortuno, J.C., Matsukura, T., Laugel, T., Padovani, P., Bellamy, F. and Edgar, A.D. (2001), "Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis", Atheroslerosis, Vol. 155, pp. 359-70.
18. Tangirala, R.K., Kazuhisa, K., Chun, S.H., Usher, D., Pure, E. and Rader, D.J. (1999), "Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice", Circulation, Vol. 100, pp. 1816-22.
19. Tomoda, M., Gonda, R., Kasahara, Y. and Hikino, H. (1986), "Antidiabetes drugs. Glycan structures of ganoderan B and C, hypoglycemic glycans of Ganoderma lucidum fruit bodies", Phytochemistry, Vol. 25, pp. 2817-70.
20. Yang, Q.Y., Fang, J.N. and Yang, X.T. (1995), "The isolation and identification of two polysaccarides of Ganoderma lucidum (GL-A, GL-B)", in Bachanan, P.K., Hseu, R.S. and Monocalno, J.M. (Eds), Ganoderma: Systematics, Phytopathology and Pharmacology, Proceeding of Contributed Symposium 59A-B, 5th International Mycological Mycological Congress, Vancouver, pp. 95-9.
21. Yang, Q.Y. and Wong, M.M. (1994), "The effect of Ganoderma lucidum extract against fatigue and endurance in the absence of oxygen", Proceedings of Contributed Symposium 59A-B, 5th International Mycological Congress Vancouver, pp. 101-4.
22. Yasuo, K., Masato, S., Yoshiko, S. and Yoshihito, S. (1989), "Ganoderic acid and its derivatives as cholesterol synthesis inhibitors", Chemical & Pharmaceutical Bulletin, Vol. 37 No. 2, pp. 531-3.
23. Yen, G.C. and Wu, J.Y. (1996), "Antioxidant and radical scarenging activities of extracts from Ganoderma tsugae", Taipei International Ganoderma Research Conference, pp. 4-5.